Reuters logo
BRIEF-Chiome Bioscience receives patent in US
March 14, 2017 / 6:22 AM / 7 months ago

BRIEF-Chiome Bioscience receives patent in US

March 14 (Reuters) - Chiome Bioscience Inc :

* Says it received patent in the U.S. for its product ANTI-HUMAN TROP-2 ANTIBODY HAVING ANTI-TUMOR ACTIVITY IN VIVO

Source text in Japanese:goo.gl/Isq1Rs

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below